Industrials -
Security & Protection Services - NYSE - US
$ 130.21
-2.94 %
$ 5.11 B
Market Cap
18.08
P/E
1. INTRINSIC VALUE
Balance Sheet
MSA Safety Incorporated
| Current Assets | 803 M |
| Cash & Short-Term Investments | 165 M |
| Receivables | 0 |
| Other Current Assets | 638 M |
| Non-Current Assets | 1.4 B |
| Long-Term Investments | 0 |
| PP&E | 268 M |
| Other Non-Current Assets | 1.13 B |
| Current Liabilities | 288 M |
| Accounts Payable | 108 M |
| Short-Term Debt | 26.4 M |
| Other Current Liabilities | 154 M |
| Non-Current Liabilities | 774 M |
| Long-Term Debt | 46 M |
| Other Non-Current Liabilities | 728 M |
EFFICIENCY
Earnings Waterfall
MSA Safety Incorporated
| Revenue | 1.81 B |
| Cost Of Revenue | 948 M |
| Gross Profit | 860 M |
| Operating Expenses | 471 M |
| Operating Income | 389 M |
| Other Expenses | 104 M |
| Net Income | 285 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
MSA Safety Incorporated
| Net Income | 285 M |
| Depreciation & Amortization | 64.3 M |
| Capital Expenditures | -54.2 M |
| Stock-Based Compensation | 18.2 M |
| Change in Working Capital | -59.4 M |
| Others | -71 M |
| Free Cash Flow | 242 M |
Wall Street Analysts Price Targets
MSA Safety Incorporated
Wall Street analysts predict an average 1-year price target for MSA of $188 , with forecasts ranging from
a
low of
$152 to a high of $200 .
MSA Lowest Price Target
Wall Street Target
152 USD
16.73%
MSA Average Price Target
Wall Street Target
188 USD
44.69%
MSA Highest Price Target
Wall Street Target
200 USD
53.60%
4. DIVIDEND
ANALYSIS
0.31%
DIVIDEND YIELD
0.51 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
MSA Safety Incorporated
Sold
0-3 MONTHS
114 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
1.88 M USD 1
9-12 MONTHS
2.04 M USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
BioArctic receives Orphan Drug Designation for exidavnemab the US
STOCKHOLM , March 17, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation (ODD) to exidavnemab for the treatment of Multiple System Atrophy (MSA), providing incentives for the development of treatments for rare diseases with a high medical need. Multiple System Atrophy (MSA) is a rapidly progressive and fatal rare disease affecting the central and autonomic nervous systems.
prnewswire.com
- 4 weeks ago
MSA Safety CFO Lee McChesney Resigns to Accept New Opportunity; Elyse Brody Appointed Interim CFO
PITTSBURGH , March 13, 2025 /PRNewswire/ -- MSA Safety Incorporated (NYSE: MSA) today announced it has accepted the resignation of its Chief Financial Officer, Lee B. McChesney, effective March 21, 2025.
prnewswire.com
- 1 month ago
MSA Safety Incorporated (MSA) Q4 2024 Earnings Call Transcript
MSA Safety Incorporated (NYSE:MSA ) Q4 2024 Earnings Conference Call February 13, 2025 10:00 AM ET Company Participants Larry De Maria - Executive Director of IR Steven Blanco - President and CEO Lee McChesney - SVP and CFO Conference Call Participants Ross Sparenblek - William Blair Saree Boroditsky - Jefferies Jeff Van Sinderen - B. Riley FBR Operator Good day, and welcome to the MSA Safety Fourth Quarter and Full Year 2024 Earnings Conference Call.
seekingalpha.com
- 2 months ago
MSA Safety (MSA) Tops Q4 Earnings Estimates
MSA Safety (MSA) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.06 per share a year ago.
zacks.com
- 2 months ago
MSA Safety Announces Fourth Quarter and Full Year 2024 Results
Fourth Quarter 2024 Highlights Achieved net sales of $500 million, a 1% GAAP increase and 2% organic(a) increase year-over-year Generated GAAP operating income of $118 million, or 23.5% of sales, and adjusted operating income of $120 million, or 24.0% of sales Recorded GAAP net income of $88 million, or $2.22 per diluted share, and adjusted earnings of $89 million, or $2.25 per diluted share Invested $14 million for capital expenditures, repaid $43 million of debt, returned $20 million to shareholders through dividends and repurchased $10 million of common stock Full Year 2024 Highlights Achieved net sales of $1.8 billion, a 1% GAAP increase and 2% organic increase year-over-year Generated GAAP operating income of $389 million, or 21.5% of sales, and adjusted operating income of $414 million, or 22.9% of sales Recorded GAAP earnings of $285 million, or $7.21 per diluted share, and adjusted earnings of $305 million, or $7.70 per diluted share Invested $54 million for capital expenditures, repaid $94 million of debt, returned $79 million to shareholders through dividends and repurchased $30 million of common stock Improved strong financial position with net leverage of 0.7x and ample liquidity PITTSBURGH , Feb. 12, 2025 /PRNewswire/ -- Global safety equipment and solutions provider MSA Safety Incorporated (NYSE: MSA) today reported financial results for the fourth quarter and year ended December 31, 2024. (a) Definition of organic revenue growth provided on the bottom of page eight.
prnewswire.com
- 2 months ago
MSA Safety Showcasing Automatic Leak Detection and Monitoring Expertise at AHR Expo
MSA to Feature FieldServer Gateways Designed to Enhance Network Protocol Connectivity PITTSBURGH , Feb. 6, 2025 /PRNewswire/ -- The spotlight on refrigerant leak detection, monitoring and reporting has never been brighter as the HVAC and refrigeration (HVAC-R) industry navigates regulatory changes in their market. To help HVAC-R businesses address these changes, MSA Safety, Inc. (NYSE: MSA) will be showcasing its leak detection and monitoring management solution capabilities at next week's AHR Expo in Orlando, Florida, February 10th through 12th.
prnewswire.com
- 2 months ago
MSA Safety Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call
PITTSBURGH , Feb. 3, 2025 /PRNewswire/ -- MSA Safety Incorporated (NYSE: MSA), a global leader in the development of advanced safety products and solutions that protect people and facility infrastructures, today announced that it will host the company's fourth quarter and full year 2024 earnings conference call on Thursday, February 13, 2025, at 10:00 a.m. Eastern Time.
prnewswire.com
- 2 months ago
Appendix 4C – Q2 FY25 Quarterly Cash Flow Report
Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025 ATH434-201 trial in early-stage MSA completed in November 2024 Positive interim data presented at MDS from the ATH434-202 Phase 2 trial in advanced MSA Multiple data presentations and publications showing the potential for ATH434 to modify disease progression in neurodegenerative conditions Cash balance on 31 December 2024 of A$4.54 m MELBOURNE, Australia and SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today released its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 31 December 2024 (Q2 FY25). “The second fiscal quarter of this year was extremely productive for Alterity and highlighted the tremendous potential of our lead asset, ATH434, as a promising therapy to treat a variety of neurodegenerative diseases,” said, David Stamler, M.D.
globenewswire.com
- 2 months ago
2 Magnificent Dividend Kings Down 19% and 32% to Buy in 2025
Today's Dividends Kings are a who's-who of the most successful dividend growth stocks of our time. This list consists of about 50 publicly traded companies that have increased their dividend payments annually for a minimum of half a century.
fool.com
- 2 months ago
7 A-Rated Dividend Aristocrat Bargains With Big Upside Potential In 2025
Seven Dividend Aristocrats are trading at 52-week lows, but if they return to their historical fair value, they could offer a 34% upside potential in 2025. These aristocrats have strong fundamentals, including a 2.1% yield, A-credit ratings, and an average 41-year dividend growth streak. Historically, these stocks have outperformed the S&P 500 with lower volatility, delivering consistent returns and robust income growth.
seekingalpha.com
- 2 months ago
Will MSA Safety (MSA) Beat Estimates Again in Its Next Earnings Report?
MSA Safety (MSA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zacks.com
- 3 months ago
MSA Safety Declares Quarterly Dividend
PITTSBURGH , Jan. 15, 2025 /PRNewswire/ -- The Board of Directors of MSA Safety Incorporated (NYSE: MSA) today declared a first quarter dividend of $0.51 per share on common stock, payable March 10, 2025, to shareholders of record on February 14, 2025. The Board also declared a dividend of $0.5625 per share on preferred stock, payable March 1, 2025, to shareholders of record on February 14, 2025.
prnewswire.com
- 3 months ago
8. Profile
Summary
MSA Safety Incorporated MSA
COUNTRY
US
INDUSTRY
Security & Protection Services
MARKET CAP
$ 5.11 B
Dividend Yield
0.31%
Description
MSA Safety Incorporated develops, manufactures, and supplies safety products that protect people and facility infrastructures in the oil, gas, petrochemical, fire service, construction, industrial manufacturing applications, utilities, military, and mining industries in North America, Latin America, and internationally. The company's core product offerings include permanently installed fixed gas and flame detection instruments, such as permanently installed gas detection monitoring systems, and flame detectors and open-path infrared gas detectors, as well as replacement components and related services to detect the presence or absence of various gases in the air. Its core product offerings also comprise breathing apparatus products, such as self-contained breathing apparatus; hand-held portable gas detection instruments; industrial head protection products; firefighter helmets and protective apparel; and fall protection equipment, including confined space equipment, harnesses, lanyards, and self-retracting lifelines, as well as engineered systems. In addition, the company offers air-purifying respirators, eye and face protection products, ballistic helmets, and gas masks. It serves distributors and end-users through indirect and direct sales channels. The company offers its product under the V-Gard, Cairns, and Gallet brand names. MSA Safety Incorporated was founded in 1914 and is based in Cranberry Township, Pennsylvania.
Contact
1000 Cranberry Woods Drive, Cranberry Township, PA, 16066-5207
https://www.msasafety.com
IPO
Date
Feb. 22, 1973
Employees
5200
Officers
Mr. Steven C. Blanco Sr.
President, Chief Executive Officer & Director